KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Jazz Pharmaceuticals (JAZZ) Interest Coverage Ratio (2010 - 2013)

Jazz Pharmaceuticals' quarterly Interest Coverage Ratio came in at 163.78 in Q3 2013, up 225.48% year-on-year from 50.32 in Q3 2012, and down 18.18% quarter-over-quarter from 200.17 in Q2 2013.

Jazz Pharmaceuticals has reported Interest Coverage Ratio for 4 years, with the latest figure at 163.78 in Q3 2013.

  • For the quarter ending Q3 2013, Interest Coverage Ratio rose 225.48% year-over-year to 163.78; the trailing twelve-month figure through Jun 2014 stood at 301.72 (up 291.44% YoY), and the FY2013 full-year result was 200.54, up 266.93% from the prior year.
  • Interest Coverage Ratio for Q3 2013 stood at 163.78, down from 200.17 in the prior quarter.
  • The five-year high for Interest Coverage Ratio was 200.17 in Q2 2013, with the low at 251.61 in Q1 2013.
  • Average Interest Coverage Ratio over 4 years is 40.54, with a median of 41.5 recorded in 2010.
  • Peak annual rise in Interest Coverage Ratio reached 225.48% in 2013, while the deepest fall reached 21.85% in 2013.
  • Tracing JAZZ's Interest Coverage Ratio over 4 years: stood at 44.8 in 2010, then surged by 214.69% to 51.38 in 2011, then plunged by 42.05% to 29.77 in 2012, then surged by 450.07% to 163.78 in 2013.
  • The last three Interest Coverage Ratio figures came in at 163.78 (Q3 2013), 200.17 (Q2 2013), and 251.61 (Q1 2013), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Interest Cover (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -129.79
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 3.58
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -258.33
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn -
7 Evaxion A 62.56 Bn 62.54 Bn - 11.50
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 49.84
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 3.88
10 Jazz Pharmaceuticals 14.35 Bn 12.51 Bn 934.80 Mn -

Historic Data

Download Data 🔒
DateValue
Sep 30, 2013 163.78
Jun 30, 2013 200.17
Mar 31, 2013 -251.61
Dec 31, 2012 29.77
Sep 30, 2012 50.32
Jun 30, 2012 164.28
Jun 30, 2011 51.38
Mar 31, 2011 29.09
Dec 31, 2010 -44.80
Sep 30, 2010 12.07
Jun 30, 2010 41.50